Rob graduated from the University of Exeter with a BSc in Biosciences in 2012 and has since been working in the biotechnology and biopharmaceutical industries. After a while at Shell Global Solutions, where he investigated the use of synthetic biology for the creation of novel metabolic pathways for biofuel production, he joined UCB, where he expressed recombinant antibody fragments in bacteria for the development of novel therapeutic drugs. In his spare time, Rob likes to eat burgers, play football with his friends and occasionally runs, but only if the weather is nice.